Global Acute Myeloid Leukemia Drugs Industry Research Report 2020, Forecast to 2025

June 2020 | 108 pages | ID: G9EC8689E3C3EN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Scope of the Report

The Acute Myeloid Leukemia Drugs market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Acute Myeloid Leukemia Drugs is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Acute Myeloid Leukemia Drugs industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Acute Myeloid Leukemia Drugs by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Acute Myeloid Leukemia Drugs market are discussed.

The market is segmented by types:

• DC regimen
• AVD Regimen
• VCD regimen

It can be also divided by applications:

• Hospital
• Clinic
• Others

And this report covers the historical situation, present status and the future prospects of the global Acute Myeloid Leukemia Drugs market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• Ambit Biosciences Corporation
• Clavis Pharma
• Celgene Corporation
• Sunesis Pharmaceuticals
• Cephalon
• Genzyme Corporation
• Eisai

Report Includes:

• xx data tables and xx additional tables
• An overview of global Acute Myeloid Leukemia Drugs market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Acute Myeloid Leukemia Drugs market
• Profiles of major players in the industry, including - Ambit Biosciences Corporation, Clavis Pharma, Celgene Corporation, Sunesis Pharmaceuticals, Cephalon.....

Research objectives

• To study and analyze the global Acute Myeloid Leukemia Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Acute Myeloid Leukemia Drugs market by identifying its various subsegments.
• Focuses on the key global Acute Myeloid Leukemia Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Acute Myeloid Leukemia Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Acute Myeloid Leukemia Drugs submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Acute Myeloid Leukemia Drugs Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Acute Myeloid Leukemia Drugs Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 ACUTE MYELOID LEUKEMIA DRUGS INDUSTRY OVERVIEW

2.1 Global Acute Myeloid Leukemia Drugs Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Acute Myeloid Leukemia Drugs Global Import Market Analysis
  2.1.2 Acute Myeloid Leukemia Drugs Global Export Market Analysis
  2.1.3 Acute Myeloid Leukemia Drugs Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 DC regimen
  2.2.2 AVD Regimen
  2.2.3 VCD regimen
2.3 Market Analysis by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Others
2.4 Global Acute Myeloid Leukemia Drugs Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Acute Myeloid Leukemia Drugs Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Acute Myeloid Leukemia Drugs Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Acute Myeloid Leukemia Drugs Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Acute Myeloid Leukemia Drugs Manufacturer Market Share
  2.4.5 Top 10 Acute Myeloid Leukemia Drugs Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Acute Myeloid Leukemia Drugs Market
  2.4.7 Key Manufacturers Acute Myeloid Leukemia Drugs Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Acute Myeloid Leukemia Drugs Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Acute Myeloid Leukemia Drugs Industry Impact
  2.7.1 How the Covid-19 is Affecting the Acute Myeloid Leukemia Drugs Industry
  2.7.2 Acute Myeloid Leukemia Drugs Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Acute Myeloid Leukemia Drugs Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Acute Myeloid Leukemia Drugs Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL ACUTE MYELOID LEUKEMIA DRUGS MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Acute Myeloid Leukemia Drugs Sales Market Share by Region
4.2 Global Acute Myeloid Leukemia Drugs Revenue Market Share by Region (2015-2019)
4.3 Global Acute Myeloid Leukemia Drugs Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Acute Myeloid Leukemia Drugs Market Size Detail
  4.4.1 North America Acute Myeloid Leukemia Drugs Sales Growth Rate (2015-2020)
  4.4.2 North America Acute Myeloid Leukemia Drugs Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Acute Myeloid Leukemia Drugs Market Size Detail
  4.5.1 Europe Acute Myeloid Leukemia Drugs Sales Growth Rate (2015-2020)
  4.5.2 Europe Acute Myeloid Leukemia Drugs Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Acute Myeloid Leukemia Drugs Market Size Detail
  4.6.1 Japan Acute Myeloid Leukemia Drugs Sales Growth Rate (2015-2020)
  4.6.2 Japan Acute Myeloid Leukemia Drugs Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Acute Myeloid Leukemia Drugs Market Size Detail
  4.7.1 China Acute Myeloid Leukemia Drugs Sales Growth Rate (2015-2020)
  4.7.2 China Acute Myeloid Leukemia Drugs Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL ACUTE MYELOID LEUKEMIA DRUGS MARKET SEGMENT BY TYPE

5.1 Global Acute Myeloid Leukemia Drugs Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Acute Myeloid Leukemia Drugs Sales and Market Share by Type (2015-2020)
  5.1.2 Global Acute Myeloid Leukemia Drugs Revenue and Market Share by Type (2015-2020)
5.2 DC regimen Sales Growth Rate and Price
  5.2.1 Global DC regimen Sales Growth Rate (2015-2020)
  5.2.2 Global DC regimen Price (2015-2020)
5.3 AVD Regimen Sales Growth Rate and Price
  5.3.1 Global AVD Regimen Sales Growth Rate (2015-2020)
  5.3.2 Global AVD Regimen Price (2015-2020)
5.4 VCD regimen Sales Growth Rate and Price
  5.4.1 Global VCD regimen Sales Growth Rate (2015-2020)
  5.4.2 Global VCD regimen Price (2015-2020)

6 GLOBAL ACUTE MYELOID LEUKEMIA DRUGS MARKET SEGMENT BY APPLICATION

6.1 Global Acute Myeloid Leukemia DrugsSales Market Share by Application (2015-2020)
6.2 Hospital Sales Growth Rate (2015-2020)
6.3 Clinic Sales Growth Rate (2015-2020)
6.4 Others Sales Growth Rate (2015-2020)

7 GLOBAL ACUTE MYELOID LEUKEMIA DRUGS MARKET FORECAST

7.1 Global Acute Myeloid Leukemia Drugs Sales, Revenue Forecast
  7.1.1 Global Acute Myeloid Leukemia Drugs Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Acute Myeloid Leukemia Drugs Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Acute Myeloid Leukemia Drugs Price and Trend Forecast (2020-2025)
7.2 Global Acute Myeloid Leukemia Drugs Sales Forecast by Region (2020-2025)
  7.2.1 North America Acute Myeloid Leukemia Drugs Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Acute Myeloid Leukemia Drugs Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Acute Myeloid Leukemia Drugs Production, Revenue Forecast (2020-2025)
  7.2.4 China Acute Myeloid Leukemia Drugs Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF ACUTE MYELOID LEUKEMIA DRUGS INDUSTRY KEY MANUFACTURERS

8.1 Ambit Biosciences Corporation
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 Ambit Biosciences Corporation Acute Myeloid Leukemia Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 Ambit Biosciences Corporation News
8.2 Clavis Pharma
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Clavis Pharma Acute Myeloid Leukemia Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Clavis Pharma News
8.3 Celgene Corporation
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Celgene Corporation Acute Myeloid Leukemia Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Celgene Corporation News
8.4 Sunesis Pharmaceuticals
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 Sunesis Pharmaceuticals News
8.5 Cephalon
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 Cephalon Acute Myeloid Leukemia Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 Cephalon News
8.6 Genzyme Corporation
  8.6.1 Company Details
  8.6.2 Product Information
  8.6.3 Genzyme Corporation Acute Myeloid Leukemia Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.6.4 Main Business Overview
  8.6.5 Genzyme Corporation News
8.7 Eisai
  8.7.1 Company Details
  8.7.2 Product Information
  8.7.3 Eisai Acute Myeloid Leukemia Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.7.4 Main Business Overview
  8.7.5 Eisai News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Acute Myeloid Leukemia Drugs Picture
Figure Research Programs/Design for This Report
Figure Global Acute Myeloid Leukemia Drugs Market by Regions (2019)
Table Global Market Acute Myeloid Leukemia Drugs Comparison by Regions (M USD) 2019-2025
Table Global Acute Myeloid Leukemia Drugs Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Acute Myeloid Leukemia Drugs by Type in 2019
Figure DC regimen Picture
Figure AVD Regimen Picture
Figure VCD regimen Picture
Table Global Acute Myeloid Leukemia Drugs Sales by Application (2019-2025)
Figure Global Acute Myeloid Leukemia Drugs Sales Market Share by Application in 2019
Figure Hospital Picture
Figure Clinic Picture
Figure Others Picture
Table Global Acute Myeloid Leukemia Drugs Sales by Manufacturer (2018-2020)
Figure Global Acute Myeloid Leukemia Drugs Sales Market Share by Manufacturer in 2019
Table Global Acute Myeloid Leukemia Drugs Revenue by Manufacturer (2018-2020)
Figure Global Acute Myeloid Leukemia Drugs Revenue Market Share by Manufacturer in 2019
Table Global Acute Myeloid Leukemia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Acute Myeloid Leukemia Drugs Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Acute Myeloid Leukemia Drugs Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Acute Myeloid Leukemia Drugs Market
Table Key Manufacturers Acute Myeloid Leukemia Drugs Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Acute Myeloid Leukemia Drugs
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Acute Myeloid Leukemia Drugs Sales (K Units) by Region (2015-2020)
Table Global Acute Myeloid Leukemia Drugs Sales Market Share by Region (2015-2019)
Figure Global Acute Myeloid Leukemia Drugs Sales Market Share by Region (2015-2019)
Figure Global Acute Myeloid Leukemia Drugs Sales Market Share by Region in 2018
Table Global Acute Myeloid Leukemia Drugs Revenue (Million US$) by Region (2015-2020)
Table Global Acute Myeloid Leukemia Drugs Revenue Market Share by Region (2015-2020)
Figure Global Acute Myeloid Leukemia Drugs Revenue Market Share by Region (2015-2020)
Figure Global Acute Myeloid Leukemia Drugs Revenue Market Share by Region in 2019
Table Global Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Acute Myeloid Leukemia Drugs Sales (K Units) Growth Rate (2015-2020)
Table North America Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Acute Myeloid Leukemia Drugs Sales (K Units) Growth Rate (2015-2020)
Table Europe Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Acute Myeloid Leukemia Drugs Sales (K Units) Growth Rate (2015-2020)
Table Japan Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Acute Myeloid Leukemia Drugs Sales (K Units) Growth Rate (2015-2020)
Table China Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Acute Myeloid Leukemia Drugs Sales by Type (2015-2020)
Table Global Acute Myeloid Leukemia Drugs Sales Market Share by Type (2015-2020)
Figure Global Acute Myeloid Leukemia Drugs Sales Market Share by Type in 2019
Table Global Acute Myeloid Leukemia Drugs Revenue by Type (2015-2020)
Table Global Acute Myeloid Leukemia Drugs Revenue Market Share by Type (2015-2020)
Figure Global Acute Myeloid Leukemia Drugs Revenue Market Share by Type in 2019
Figure Global DC regimen Sales Growth Rate (2015-2020)
Figure Global DC regimen Price (2015-2020)
Figure Global AVD Regimen Sales Growth Rate (2015-2020)
Figure Global AVD Regimen Price (2015-2020)
Figure Global VCD regimen Sales Growth Rate (2015-2020)
Figure Global VCD regimen Price (2015-2020)
Table Global Acute Myeloid Leukemia Drugs Sales by Application (2015-2020)
Table Global Acute Myeloid Leukemia Drugs Sales Market Share by Application (2015-2020)
Figure Global Acute Myeloid Leukemia Drugs Sales Market Share by Application in 2019
Figure Global Hospital Sales Growth Rate (2015-2020)
Figure Global Clinic Sales Growth Rate (2015-2020)
Figure Global Others Sales Growth Rate (2015-2020)
Figure Global Acute Myeloid Leukemia Drugs Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Acute Myeloid Leukemia Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Acute Myeloid Leukemia Drugs Price and Trend Forecast (2020-2025)
Table Global Acute Myeloid Leukemia Drugs Sales (K Units) Forecast by Region (2020-2025)
Figure Global Acute Myeloid Leukemia Drugs Production Market Share Forecast by Region (2020-2025)
Figure North America Acute Myeloid Leukemia Drugs Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Acute Myeloid Leukemia Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Acute Myeloid Leukemia Drugs Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Acute Myeloid Leukemia Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Acute Myeloid Leukemia Drugs Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Acute Myeloid Leukemia Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Acute Myeloid Leukemia Drugs Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Acute Myeloid Leukemia Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Ambit Biosciences Corporation Company Profile
Figure Acute Myeloid Leukemia Drugs Product Picture and Specifications of Ambit Biosciences Corporation
Table Acute Myeloid Leukemia Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Ambit Biosciences Corporation Acute Myeloid Leukemia Drugs Market Share (2018-2020)
Table Ambit Biosciences Corporation Main Business
Table Ambit Biosciences Corporation Recent Development
Table Clavis Pharma Company Profile
Figure Acute Myeloid Leukemia Drugs Product Picture and Specifications of Clavis Pharma
Table Acute Myeloid Leukemia Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Clavis Pharma Acute Myeloid Leukemia Drugs Market Share (2018-2020)
Table Clavis Pharma Main Business
Table Clavis Pharma Recent Development
Table Celgene Corporation Company Profile
Figure Acute Myeloid Leukemia Drugs Product Picture and Specifications of Celgene Corporation
Table Acute Myeloid Leukemia Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Celgene Corporation Acute Myeloid Leukemia Drugs Market Share (2018-2020)
Table Celgene Corporation Main Business
Table Celgene Corporation Recent Development
Table Sunesis Pharmaceuticals Company Profile
Figure Acute Myeloid Leukemia Drugs Product Picture and Specifications of Sunesis Pharmaceuticals
Table Acute Myeloid Leukemia Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Sunesis Pharmaceuticals Acute Myeloid Leukemia Drugs Market Share (2018-2020)
Table Sunesis Pharmaceuticals Main Business
Table Sunesis Pharmaceuticals Recent Development
Table Cephalon Company Profile
Figure Acute Myeloid Leukemia Drugs Product Picture and Specifications of Cephalon
Table Acute Myeloid Leukemia Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Cephalon Acute Myeloid Leukemia Drugs Market Share (2018-2020)
Table Cephalon Main Business
Table Cephalon Recent Development
Table Genzyme Corporation Company Profile
Figure Acute Myeloid Leukemia Drugs Product Picture and Specifications of Genzyme Corporation
Table Acute Myeloid Leukemia Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Genzyme Corporation Acute Myeloid Leukemia Drugs Market Share (2018-2020)
Table Genzyme Corporation Main Business
Table Genzyme Corporation Recent Development
Table Eisai Company Profile
Figure Acute Myeloid Leukemia Drugs Product Picture and Specifications of Eisai
Table Acute Myeloid Leukemia Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Eisai Acute Myeloid Leukemia Drugs Market Share (2018-2020)
Table Eisai Main Business
Table Eisai Recent Development
Table of Appendix